HomeVIRP • EPA
add
Virbac SA
Previous close
€345.50
Day range
€343.00 - €352.00
Year range
€239.00 - €377.50
Market cap
2.96B EUR
Avg Volume
2.10K
P/E ratio
24.38
Dividend yield
0.38%
Primary exchange
EPA
Market news
NDAQ
1.98%
1.73%
1.01%
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 318.22M | 6.10% |
Operating expense | 165.89M | 1.62% |
Net income | 23.13M | 4.21% |
Net profit margin | 7.27 | -1.76% |
Earnings per share | — | — |
EBITDA | 47.91M | 12.00% |
Effective tax rate | 28.50% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 178.40M | -0.82% |
Total assets | 1.46B | 9.16% |
Total liabilities | 545.81M | 10.41% |
Total equity | 909.92M | — |
Shares outstanding | 8.37M | — |
Price to book | 3.21 | — |
Return on assets | 6.72% | — |
Return on capital | 9.47% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 23.13M | 4.21% |
Cash from operations | 51.06M | -9.10% |
Cash from investing | -44.83M | -208.82% |
Cash from financing | -21.04M | 24.02% |
Net change in cash | -13.50M | -217.10% |
Free cash flow | 16.34M | -10.40% |
About
Virbac is a French company dedicated to animal health located in Carros, near Nice. It was founded in 1968 by veterinarian Pierre-Richard Dick.
The company is the 6th the largest veterinarian pharmaceutical group with a turnover of 1,247 million euros in 2023. The company is a limited company with a board Euronext Paris stock exchange - compartiment A and is part of the reference index: SBF 120, and eligible SRD, PEA and PEA-PME. Wikipedia
Founded
1968
Headquarters
Website
Employees
5,459